The Board of Directors of iNtRON Biotechnology, Inc. has authorized a buyback plan on June 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,370 KRW | +2.74% |
|
+2.08% | -27.45% |
06-19 | INtRON Biotechnology, Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
06-19 | INtRON Biotechnology, Inc. authorizes a Buyback Plan. | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.45% | 153M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- INtRON Biotechnology, Inc. authorizes a Buyback Plan.